All papers will be published Open Access
Proposals accepted until May 1, 2020
SLAS Discovery Editor-in-Chief Bob Campbell, Ph.D., (Senior Research Advisor, Eli Lilly & Company) and Editorial Board Member Timothy P. Spicer, Ph.D., (Senior Scientific Director, Department of Molecular Medicine, Scripps Research) invite the submission of manuscript proposals (abstracts) around COVID-19/SARS-CoV-2 or related viruses for publication in a special collection. Abstracts will be used to select and invite papers for review and publication consideration.
Drs. Campbell and Spicer seek high-quality, short- or full-length research reports, reviews and perspectives related to the approaches of identifying anti-viral compounds/therapies focusing on COVID-19/SARS-CoV-2 or related viruses. Abstracts are welcome from academia, industry and vendors.
Submit your manuscript proposal before May 1, 2020. Extensions are available by request. Proposals should include your name, contact information, affiliation, a working title and abstract (250-500 words) as an MS Word document.
Invited manuscripts will need to be completed and submitted by July 1, 2020. All submitted papers will be subject to peer-review to ensure scientific rigor, clarity of expression and integration with other contributions in the SLAS Discovery Special Collection. All papers will be published Open Access immediately upon publication, and all papers will be published online ahead of print to ensure they are available to readers as soon as possible.
Questions? Please e-mail firstname.lastname@example.org or call +1.630.256.7527, ext. 106.